Turnstone Biologics Corp. (TSBX)
(Delayed Data from NSDQ)
$2.51 USD
0.00 (0.00%)
Updated Jul 25, 2024 03:59 PM ET
After-Market: $2.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/6/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -0.85 |
Last EPS Surprise | -8.97% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.44 |
Next Year | -3.01 |
EPS (TTM) | -10.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 19.31M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.69 | -3.44 | -3.01 |
# of Estimates | 2 | 1 | 3 | 3 |
Most Recent Consensus | NA | NA | -4.49 | -3.92 |
High Estimate | -0.81 | -0.69 | -2.88 | -2.37 |
Low Estimate | -0.87 | -0.69 | -4.49 | -3.92 |
Year ago EPS | -7.56 | -1.00 | -4.78 | -3.44 |
Year over Year Growth Est. | 88.89% | 31.00% | 28.03% | 12.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.69 | -3.44 | -3.01 |
7 Days Ago | -0.84 | -0.69 | -3.44 | -3.01 |
30 Days Ago | -0.84 | -0.69 | -3.44 | -3.01 |
60 Days Ago | -0.84 | -0.69 | -3.44 | -3.01 |
90 Days Ago | -0.73 | -0.58 | -3.34 | -3.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.69 | -3.44 | -3.01 |
Zacks Consensus Estimate | -0.84 | -0.69 | -3.44 | -3.01 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.85 | -0.73 | -1.00 | -7.56 | NA |
Estimate | -0.78 | -0.86 | -0.67 | NA | NA |
Difference | -0.07 | 0.13 | -0.33 | NA | -0.09 |
Surprise | -8.97% | 15.12% | -49.25% | NA | -14.37% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more